The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease.
from NYT > Top Stories https://ift.tt/3701CCf
November 22, 2020 at 06:33AM
0 Comments